Home Monitoring for Age-related Macular Degeneration

This article seeks to summarize the history of patient-based monitoring systems for age-related macular degeneration, as well as recent new and emerging technologies in the field of home surveillance.New commercially available products, such as ForeseeHome and Paxos, offer improved modalities for home monitoring of macular degeneration, and home optical coherence tomography provides the potential for further improvement in the future.While traditional Amsler grid monitoring has provided a useful test for patients to monitor their vision, it has found to have limited specificity and sensitivity as a screening tool for neovascular macular degeneration. Technologies such as ForeseeHome offer a new standard of care with improved accuracy in detection neovascularization early in its disease course, allowing for early intervention to improve patient outcomes